CY1119373T1 - Βελτιωμενες διαδικασιες για παρασκευη υδραζιδιων - Google Patents

Βελτιωμενες διαδικασιες για παρασκευη υδραζιδιων

Info

Publication number
CY1119373T1
CY1119373T1 CY20171100991T CY171100991T CY1119373T1 CY 1119373 T1 CY1119373 T1 CY 1119373T1 CY 20171100991 T CY20171100991 T CY 20171100991T CY 171100991 T CY171100991 T CY 171100991T CY 1119373 T1 CY1119373 T1 CY 1119373T1
Authority
CY
Cyprus
Prior art keywords
water production
hydrazine
preparation
acyl chloride
improved procedures
Prior art date
Application number
CY20171100991T
Other languages
English (en)
Inventor
George A Chiarello
Ayman Sahli
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of CY1119373T1 publication Critical patent/CY1119373T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/20Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/46Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms
    • C07C323/48Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms to nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6889Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C241/00Preparation of compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C241/04Preparation of hydrazides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C07C243/26Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C243/28Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of a saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/02Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
    • C07C319/12Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols by reactions not involving the formation of mercapto groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coating Apparatus (AREA)

Abstract

Μία μέθοδος γνωστοποιείται για παρασκευή υδραζιδίων από υδραζίνη και ένα ακυλοχλωρίδιο η οποία περιλαμβάνει τα στάδια (a) της παρασκευής ενός αναδευόμενου ουσιαστικά ομοιόμορφου πολτού ο οποίος περιλαμβάνει υδραζίνη και έναν αδρανή διαλύτη σε χαμηλή θερμοκρασία" και (b) της προσθήκης ενός ακυλοχλωριδίου συνεχώς στον εν λόγω πολτό. Η μέθοδος αποφεύγει ή περιορίζει την παραγωγή ανεπιθύμητων παραπροϊόντων δις-υδραζιδίου. Η μέθοδος χρησιμοποιείται για παρασκευή υδραζιδίου του 3-μεθυλο-3-μερκαπτοβουτανοϊκού οξέος, ενός μορίου το οποίο χρησιμοποιείται για τη σύνδεση καλιχεαμικίνης με ένα μονόκλωνο αντίσωμα.
CY20171100991T 2007-05-22 2017-09-20 Βελτιωμενες διαδικασιες για παρασκευη υδραζιδιων CY1119373T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93952907P 2007-05-22 2007-05-22
PCT/US2008/064213 WO2008147765A1 (en) 2007-05-22 2008-05-20 Improved processes for making hydrazides

Publications (1)

Publication Number Publication Date
CY1119373T1 true CY1119373T1 (el) 2018-02-14

Family

ID=39810161

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20171100991T CY1119373T1 (el) 2007-05-22 2017-09-20 Βελτιωμενες διαδικασιες για παρασκευη υδραζιδιων
CY181100854T CY1120592T1 (el) 2007-05-22 2018-08-13 Βελτιωμενες διαδικασιες για παρασκευη υδραζιδιων

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY181100854T CY1120592T1 (el) 2007-05-22 2018-08-13 Βελτιωμενες διαδικασιες για παρασκευη υδραζιδιων

Country Status (25)

Country Link
US (5) US8110705B2 (el)
EP (2) EP2155258B1 (el)
JP (4) JP5697446B2 (el)
KR (1) KR101547705B1 (el)
CN (2) CN101835494B (el)
AR (1) AR066674A1 (el)
AU (1) AU2008256905B2 (el)
BR (1) BRPI0811140B1 (el)
CA (1) CA2687852A1 (el)
CL (1) CL2008001490A1 (el)
CY (2) CY1119373T1 (el)
DK (2) DK2155258T3 (el)
ES (2) ES2686019T3 (el)
HK (2) HK1147736A1 (el)
HU (2) HUE039657T2 (el)
IL (1) IL202242A (el)
MX (1) MX2009012587A (el)
PA (1) PA8781201A1 (el)
PE (1) PE20090305A1 (el)
PL (2) PL2155258T3 (el)
PT (2) PT2465541T (el)
SI (2) SI2465541T1 (el)
TW (1) TW200904784A (el)
WO (1) WO2008147765A1 (el)
ZA (1) ZA200908229B (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101835494B (zh) * 2007-05-22 2012-02-15 惠氏有限责任公司 制造酰肼的改良方法
PE20161413A1 (es) 2013-11-04 2017-01-10 Stemcentrx Inc Conjugados de anticuerpo anti-efna4-farmaco
CA3131631A1 (en) 2013-11-04 2015-05-07 Pfizer Inc. Intermediates and methods for synthesizing calicheamicin derivatives
KR102238032B1 (ko) 2014-04-30 2021-04-08 화이자 인코포레이티드 항-ptk7 항체-약물 접합체
WO2016105330A1 (en) * 2014-12-22 2016-06-30 Hewlett Packard Enterprise Development Lp Response to an inoperative network device managed by a controller
WO2019018647A1 (en) 2017-07-20 2019-01-24 Pfizer Inc. ANTI-GD3 ANTIBODIES AND CONJUGATES ANTIBODY-MEDICATION
EP3693452A4 (en) 2017-10-03 2021-06-23 University Public Corporation Osaka CELL CULTURE CONTAINERS, METHOD FOR CELL RECOVERY, AND METHOD FOR CULTIVATION OF CELLS
CN109574870A (zh) * 2018-12-25 2019-04-05 维思普新材料(苏州)有限公司 一种酰肼的连续制备方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US623230A (en) * 1899-04-18 Rotary ore-cooler
DE2608336A1 (de) 1975-03-11 1976-09-30 Sandoz Ag Neue organische verbindungen, ihre herstellung und verwendung
US4291022A (en) * 1975-03-11 1981-09-22 Sandoz Ltd. Organic compounds
US4671958A (en) 1982-03-09 1987-06-09 Cytogen Corporation Antibody conjugates for the delivery of compounds to target sites
US4479953A (en) * 1983-08-25 1984-10-30 Merck & Co., Inc. Pyrazine aldimine compounds as antimicrobial agents
US4970198A (en) 1985-10-17 1990-11-13 American Cyanamid Company Antitumor antibiotics (LL-E33288 complex)
DE3771413D1 (de) * 1986-08-04 1991-08-22 Sandoz Ag Benzhydroxamsaeure-derivate.
US4729781A (en) * 1986-08-04 1988-03-08 Sandoz Ltd. 3,6-dichloro-2-methoxybenzohydroxamic acid derivatives and use as herbicidal agents
US4939244A (en) 1987-01-30 1990-07-03 American Cyanamid Company Pseudoaglycones of LL-E33288 antibiotics
US5079233A (en) 1987-01-30 1992-01-07 American Cyanamid Company N-acyl derivatives of the LL-E33288 antitumor antibiotics, composition and methods for using the same
US5053394A (en) * 1988-09-21 1991-10-01 American Cyanamid Company Targeted forms of methyltrithio antitumor agents
US5770701A (en) 1987-10-30 1998-06-23 American Cyanamid Company Process for preparing targeted forms of methyltrithio antitumor agents
JPH05222044A (ja) * 1991-10-25 1993-08-31 Eastman Kodak Co 2当量ピラゾロトリアゾールマゼンタカプラーの製造
DE69217085T2 (de) * 1991-11-22 1997-05-28 Uniroyal Chem Co Inc Insekttötende phenylhydrazin-derivate
US5690904A (en) * 1993-07-12 1997-11-25 Amersham International Plc Diagnostic radiopharmaceutical compounds (That)
US5443953A (en) * 1993-12-08 1995-08-22 Immunomedics, Inc. Preparation and use of immunoconjugates
US5403015A (en) * 1993-12-09 1995-04-04 Forte; Steven L. Cards and methods for playing casino 21 or blackjack
WO1996006096A1 (fr) * 1994-08-23 1996-02-29 Nissan Chemical Industries, Ltd. Derive de pyridine
IT1292092B1 (it) 1997-06-05 1999-01-25 Geange Ltd Impiego di derivati eterociclici aromatici azotati nel trattamento topico di affezioni di tessuti epiteliali
DE69936998T2 (de) * 1998-10-16 2008-05-21 Merck Sharp & Dohme Ltd., Hoddesdon Pyrazolotriazinderivate als gaba-rezeptorliganden
GB0008696D0 (en) * 2000-04-07 2000-05-31 Merck Sharp & Dohme Therapeutic agents
CA2449544A1 (en) 2001-06-08 2002-12-19 Cytovia, Inc. Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
PL224150B1 (pl) * 2002-05-02 2016-11-30 Wyeth Corp Kompozycja zawierająca koniugat leku obejmujący pochodne kalicheamycyny i przeciwciało, oraz kompozycja farmaceutyczna ją zawierająca
US6803379B2 (en) * 2002-06-04 2004-10-12 Jose A. Fernandez-Pol Pharmacological agents and methods of treatment that inactivate pathogenic prokaryotic and eukaryotic cells and viruses by attacking highly conserved domains in structural metalloprotein and metalloenzyme targets
US7144876B2 (en) * 2002-12-18 2006-12-05 Cytovia, Inc. 3,5-Disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
RU2423353C1 (ru) 2002-12-20 2011-07-10 Глэксо Груп Лимитед Новые производные бензазепина
US7304161B2 (en) 2003-02-10 2007-12-04 Intrexon Corporation Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
EP1622615A4 (en) 2003-05-13 2009-02-18 Smithkline Beecham Corp INHIBITORS OF THE INTEGRASE OF NAPHTHYRIDINE
BRPI0412040A (pt) 2003-07-02 2006-09-05 Sugen Inc hidrazidas de indolinona como inibidores de c-met
KR20060032190A (ko) 2003-07-02 2006-04-14 버텍스 파마슈티칼스 인코포레이티드 전압 개폐 이온 채널의 조절제로서 유용한 피리미딘
SE0302486D0 (sv) 2003-09-18 2003-09-18 Astrazeneca Ab Novel compounds
EP1755574A4 (en) * 2004-04-06 2009-05-13 Semafore Pharmaceuticals Inc PTEN INHIBITORS
GT200500283A (es) * 2004-10-08 2006-05-08 Inmunoterapia de desordenes autoinmunes
TWI404706B (zh) * 2006-01-11 2013-08-11 Actelion Pharmaceuticals Ltd 新穎噻吩衍生物
CN101835494B (zh) * 2007-05-22 2012-02-15 惠氏有限责任公司 制造酰肼的改良方法

Also Published As

Publication number Publication date
DK2155258T3 (en) 2017-09-18
US20160176809A1 (en) 2016-06-23
ZA200908229B (en) 2010-08-25
HK1172008A1 (zh) 2013-04-12
AU2008256905B2 (en) 2014-05-08
US20130211053A1 (en) 2013-08-15
PE20090305A1 (es) 2009-03-15
US20080312422A1 (en) 2008-12-18
AU2008256905A1 (en) 2008-12-04
US8853451B2 (en) 2014-10-07
CY1120592T1 (el) 2019-12-11
BRPI0811140B1 (pt) 2022-08-16
ES2642888T3 (es) 2017-11-20
MX2009012587A (es) 2010-05-14
ES2686019T3 (es) 2018-10-16
HK1147736A1 (en) 2011-08-19
KR101547705B1 (ko) 2015-08-26
US8383857B2 (en) 2013-02-26
RU2009143524A (ru) 2011-06-27
PL2155258T3 (pl) 2017-12-29
KR20100031514A (ko) 2010-03-22
CN101835494A (zh) 2010-09-15
SI2155258T1 (sl) 2017-10-30
IL202242A (en) 2016-03-31
CN102558001B (zh) 2015-09-23
EP2155258B1 (en) 2017-08-16
EP2465541A1 (en) 2012-06-20
PL2465541T3 (pl) 2018-12-31
IL202242A0 (en) 2010-06-16
AR066674A1 (es) 2009-09-02
TW200904784A (en) 2009-02-01
SI2465541T1 (sl) 2018-10-30
BRPI0811140A2 (pt) 2015-10-27
US20150099865A1 (en) 2015-04-09
US20120130052A1 (en) 2012-05-24
US9738602B2 (en) 2017-08-22
CN102558001A (zh) 2012-07-11
EP2155258A1 (en) 2010-02-24
PT2465541T (pt) 2018-10-17
WO2008147765A1 (en) 2008-12-04
HUE039657T2 (hu) 2019-01-28
EP2465541B1 (en) 2018-07-18
PA8781201A1 (es) 2008-12-18
US9227924B2 (en) 2016-01-05
JP2010528031A (ja) 2010-08-19
PT2155258T (pt) 2017-10-18
JP2016026219A (ja) 2016-02-12
JP2013234203A (ja) 2013-11-21
CN101835494B (zh) 2012-02-15
HUE036704T2 (hu) 2018-07-30
JP5697446B2 (ja) 2015-04-08
CA2687852A1 (en) 2008-12-04
JP2017193584A (ja) 2017-10-26
CL2008001490A1 (es) 2008-07-25
US8110705B2 (en) 2012-02-07
DK2465541T3 (en) 2018-09-17

Similar Documents

Publication Publication Date Title
CY1119373T1 (el) Βελτιωμενες διαδικασιες για παρασκευη υδραζιδιων
CY1123817T1 (el) Μεθοδος για την παρασκευη ενωσεων που ειναι χρησιμες ως αναστολεις sglt
Prasad et al. Metal free sulfenylation and bis-sulfenylation of indoles: persulfate mediated synthesis
CY1121321T1 (el) Παρασκευη συζευγματων αντισωματoς-μεϋτανσινoεiδoυς δια μιας μεθοδου μιας βαθμιδας
CY1121002T1 (el) Μονοκλωνα αντισωματα κατα κλαουδινης-18 για τη θεραπεια του καρκινου
CY1109809T1 (el) Διαδικασια για την παρασκευη παραγωγων τετραζολης απο οργανο βοριο και οργανο αργιλιο αζιδια
CY1124387T1 (el) Μεθοδος για παραγωγη νεας χημικης ενωσης που περιεχει αζωτο ή αλατος αυτης, και παραγωγη ενδιαμεσου της ιδιας
CY1112754T1 (el) Μεθοδοι και ενδιαμεσα για την παρασκευη παραγωγων ν4-φαινυλ-κιναζολιν-4-αμινης
Petiot et al. Copper-catalyzed N-arylation of azoles and diazoles using highly functionalized trivalent organobismuth reagents
Zhang et al. A simple and straightforward synthesis of phenyl isothiocyanates, symmetrical and unsymmetrical thioureas under ball milling
CY1108792T1 (el) Παραγωγα διοξανιου-2-αλκυλκαρβαμικου, η παρασκευη τους και η εφαρμογη τους στην θεραπευτικη αγωγη
EA200901175A1 (ru) Способ получения 2,6-дихлор-4-(трифторметил)фенилгидразина, используя смеси дихлор-фтор-трифторметилбензолов
EA200701470A1 (ru) Способы получения производных 4-(фенокси-5-метилпиримидин-4-илокси)пиперидин-1-карбоновой кислоты и родственных соединений
RU2329252C1 (ru) Способ получения производных n-пиперидино-1,5-дифенилпиразол-3-карбоксамида
CY1113184T1 (el) Μεθοδος για την παρασκευη θεραπευτικως πολυτιμων παραγωγων τριφαινυλβουτενιου
RU2018132264A (ru) Промежуточные продукты в синтезе эрибулина и соответствующие способы синтеза
JP2008063336A5 (el)
EA200401551A1 (ru) Получение сульфинилацетамида
CY1119820T1 (el) Βελτιωμενη παρασκευη παραγωγων χαλκονης
Li et al. Aliphatic C–H azidation through a peroxydisulfate induced radical pathway
TW200728297A (en) Alpha functionalization of cyclic, ketalized ketones
RU2018130327A (ru) Улучшенный способ получения осимертиниба (azd9291) или его соли и "анилин-azd9291" или его соли
Kong et al. KIO 3-catalyzed cross dehydrogenative coupling reaction: sulfenylation of phenol and arylamine derivatives in water at room temperature
DE602006005349D1 (de) Verfahren zur herstellung von hydrazon-derivaten
Ai et al. Rhodium-catalyzed carbonylative coupling of alkyl halides with thiols: a radical process faster than easier nucleophilic substitution